BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1115 related articles for article (PubMed ID: 33598716)

  • 1. Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.
    Lee JT; Hesse EM; Paulin HN; Datta D; Katz LS; Talwar A; Chang G; Galang RR; Harcourt JL; Tamin A; Thornburg NJ; Wong KK; Stevens V; Kim K; Tong S; Zhou B; Queen K; Drobeniuc J; Folster JM; Sexton DJ; Ramachandran S; Browne H; Iskander J; Mitruka K
    Clin Infect Dis; 2021 Dec; 73(12):2217-2225. PubMed ID: 33598716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.
    Ao Z; Li Y; Wei J; Jiang J; Wang X; Zhang P; Liu Y; Yu H; Zhu L; Wang X; Hu Q; Duan J; Hu W; Zhang X; Wu G; Guo S
    Clin Exp Med; 2021 Aug; 21(3):361-367. PubMed ID: 33543353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Lee JS; Kim SY; Kim TS; Hong KH; Ryoo NH; Lee J; Park JH; Cho SI; Kim MJ; Kim YG; Kim B; Shin HS; Oh HS; Seo MS; Gwon TR; Kim Y; Park JS; Chin BS; Park WB; Park SS; Seong MW
    Clin Infect Dis; 2021 Nov; 73(9):e3002-e3008. PubMed ID: 33219681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
    Abu-Raddad LJ; Chemaitelly H; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Ayoub HH; Al Kanaani Z; Al Khal A; Al Kuwari E; Butt AA; Coyle P; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Bertollini R
    Clin Infect Dis; 2021 Oct; 73(7):e1830-e1840. PubMed ID: 33315061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing.
    Peltan ID; Beesley SJ; Webb BJ; Lopansri BK; Sinclair W; Jacobs JR; Brown SM
    PLoS One; 2021; 16(5):e0251214. PubMed ID: 33945583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.
    Song KH; Kim DM; Lee H; Ham SY; Oh SM; Jeong H; Jung J; Kang CK; Park JY; Kang YM; Kim JY; Park JS; Park KU; Kim ES; Kim HB
    Korean J Intern Med; 2021 Jan; 36(1):11-14. PubMed ID: 32972123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database.
    Dong X; Zhou Y; Shu XO; Bernstam EV; Stern R; Aronoff DM; Xu H; Lipworth L
    Microbiol Spectr; 2021 Sep; 9(1):e0032721. PubMed ID: 34406805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.
    Shragai T; Smith-Jeffcoat SE; Koh M; Schechter MC; Rebolledo PA; Kasinathan V; Wang Y; Hoffman A; Miller H; Tejada-Strop A; Jain S; Tamin A; Harcourt JL; Thornburg NJ; Wong P; Medrzycki M; Folster JM; Semenova V; Steward-Clark E; Drobenuic J; Biedron C; Stewart RJ; da Silva J; Kirking HL; Tate JE;
    J Infect Dis; 2022 Jan; 225(2):229-237. PubMed ID: 34216468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing.
    To KK; Hung IF; Ip JD; Chu AW; Chan WM; Tam AR; Fong CH; Yuan S; Tsoi HW; Ng AC; Lee LL; Wan P; Tso EY; To WK; Tsang DN; Chan KH; Huang JD; Kok KH; Cheng VC; Yuen KY
    Clin Infect Dis; 2021 Nov; 73(9):e2946-e2951. PubMed ID: 32840608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between Antibody Levels and SARS-Cov-2 Reinfection.
    Islamoglu MS; Cengiz M; Uysal BB; Ikitimur H; Ozdemir Z; Karamehmetoglu A; Akbulut AE; Bakdur AN; Ozdemir A; Kayıkcıoglu H; Ozdemir H; Uces R; Ersoy S; Yavuzer S
    Ann Clin Lab Sci; 2021 Nov; 51(6):750-755. PubMed ID: 34921027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of SARS-CoV-2 symptomatic reinfection in four healthcare professionals from the same hospital despite the presence of antibodies.
    Gargouri S; Souissi A; Abid N; Chtourou A; Feki-Berrajah L; Karray R; Kossentini H; Ben Ayed I; Abdelmoula F; Chakroun O; Nasri A; Hammami A; Rekik N; Masmoudi S; Karray-Hakim H; Rebai A
    Int J Infect Dis; 2022 Apr; 117():146-154. PubMed ID: 35017107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study.
    Turbett SE; Tomkins-Tinch CH; Anahtar MN; Dugdale CM; Hyle EP; Shenoy ES; Shaw B; Egbuonu K; Bowman KA; Zachary KC; Adams GC; Hooper DC; Ryan ET; LaRocque RC; Bassett IV; Triant VA; Siddle KJ; Rosenberg E; Sabeti PC; Schaffner SF; MacInnis BL; Lemieux JE; Charles RC
    Clin Infect Dis; 2023 Mar; 76(5):850-860. PubMed ID: 36268576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.
    Xia J; Zeng Y; Tan Z; Chen T; Hu W; Shuai S; Cao D; Zeng X
    AIDS Rev; 2021 Jun; 23(3):153-163. PubMed ID: 34082440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinfections from SARS-CoV-2: A Retrospective Study from the Gyncentrum Genetic Laboratory in Sosnowiec, Poland, April 2020 to July 2022.
    Morawiec E; Bednarska-Czerwińska A; Pudełko A; Zmarzły N; Rojczyk E; Madej K; Sobański D; Staszkiewicz R; Ossowski P; Boroń-Kaczmarska A; Zapletal-Pudełko K; Boroń D; Grabarek BO
    Med Sci Monit; 2023 Mar; 29():e939452. PubMed ID: 36964642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sinonasal manifestations and dynamic profile of RT-PCR results for SARS-CoV-2 in COVID-19 patients.
    Jia X; Shao S; Ren H; Xu Y; Zhao J; Zhao Y; Wang Y; Bao S; Yan J; Wang X; Zhang L
    Ann Palliat Med; 2021 Apr; 10(4):4174-4183. PubMed ID: 33832289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.
    Ford L; Lee C; Pray IW; Cole D; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie DW; Cherney B; Kirby MK; Fajardo GC; Caudill M; Langolf K; Kahrs J; Zochert T; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker PL; Bonenfant G; Zhou B; Folster JM; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard RP; Killerby ME;
    Clin Infect Dis; 2021 Sep; 73(6):e1348-e1355. PubMed ID: 33846714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 reinfection and COVID-19 severity.
    Nguyen NN; Houhamdi L; Hoang VT; Delerce J; Delorme L; Colson P; Brouqui P; Fournier PE; Raoult D; Gautret P
    Emerg Microbes Infect; 2022 Dec; 11(1):894-901. PubMed ID: 35264078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 48-Year-Old Immunocompetent Female Resident of Southern Florida with Confirmed Reinfection with P.1 (Gamma) Variant of SARS-CoV-2.
    Kim M; Poon KK; Miller N; Rubio-Gomez H
    Am J Case Rep; 2022 Jan; 23():e935329. PubMed ID: 35041639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.